MarketFriction

Dhanvantri Jeevan Rekha Ltd

BSE 531043 · Healthcare Service Provider
₹22.55 -4.25%
BSE close2026-10-01
Market cap₹10.7 Cr.
P/E20.9

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales4.905.155.445.705.425.705.835.515.847.277.247.80
Expenses4.874.685.435.455.185.515.795.375.916.986.857.51
Operating Profit0.030.470.010.250.240.190.040.14-0.070.290.390.29
OPM %0.61%9.13%0.18%4.39%4.43%3.33%0.69%2.54%-1.20%3.99%5.39%3.72%
Other Income0.070.090.070.080.100.130.110.070.090.070.100.07
Interest0.000.000.000.000.010.000.000.000.000.000.000.01
Depreciation0.250.200.180.170.160.170.070.150.160.190.190.17
Profit before tax-0.150.36-0.100.160.170.150.080.06-0.140.170.300.18
Tax %0.00%0.00%-10.00%0.00%0.00%0.00%62.50%0.00%0.00%0.00%0.00%0.00%
Net Profit-0.150.36-0.090.160.170.150.030.06-0.140.170.300.18
EPS in Rs-0.370.88-0.220.390.410.370.070.15-0.340.410.730.44
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales9.2611.1613.7416.8418.219.7816.7717.6820.4622.6525.8628.15
Expenses7.819.5311.8915.6117.5510.5315.2717.1019.6221.9325.0927.25
Operating Profit1.451.631.851.230.66-0.751.500.580.840.720.770.90
OPM %15.66%14.61%13.46%7.30%3.62%-7.67%8.94%3.28%4.11%3.18%2.98%3.20%
Other Income0.31-0.110.140.120.160.180.210.240.290.410.330.33
Interest0.080.180.220.110.040.020.020.010.010.010.010.01
Depreciation0.270.371.101.131.101.041.020.960.870.560.690.71
Profit before tax1.410.970.670.11-0.32-1.630.67-0.150.250.560.400.51
Tax %32.62%43.30%-7.46%63.64%-15.62%-12.88%28.36%46.67%36.00%8.93%2.50%
Net Profit0.950.550.730.05-0.26-1.420.49-0.220.170.510.390.51
EPS in Rs2.321.341.780.12-0.63-3.461.20-0.540.411.240.951.24
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth11%21%14%25%
Compounded Profit Growth-9%18%56%24%
Stock Price CAGR0%22%32%-12%
Return on Equity1%3%4%4%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital4.154.154.154.154.154.154.154.154.154.154.154.15
Reserves4.295.255.796.526.576.304.885.375.155.325.986.36
Borrowings0.000.001.941.950.100.100.070.000.000.000.000.00
Other Liabilities2.523.294.533.794.534.304.764.844.565.554.657.06
Total Liabilities10.9612.6916.4116.4115.3514.8513.8614.3613.8615.0214.7817.57
Fixed Assets5.057.8012.0712.2811.4410.689.728.858.548.148.418.57
CWIP1.440.000.000.000.120.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets4.474.894.344.133.794.174.145.515.326.886.379.00
Total Assets10.9612.6916.4116.4115.3514.8513.8614.3613.8615.0214.7817.57
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0.801.323.520.891.271.38-0.351.05-0.393.03-0.211.84
Cash from Investing Activity-1.41-1.33-4.00-0.57-0.31-0.140.00-0.06-0.56-0.39-0.66-0.74
Cash from Financing Activity0.420.310.87-0.21-1.96-0.04-0.05-0.090.000.000.000.00
Net Cash Flow-0.180.300.400.11-1.001.19-0.400.90-0.952.64-0.871.10
Free Cash Flow-0.64-0.26-1.57-0.420.861.16-0.430.90-1.032.57-1.050.99
CFO/OP55%91%216%48%103%209%47%70%-67%361%-29%239%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days15.1120.5011.4517.8022.329.0239.9337.2250.5831.2229.0136.98
Inventory Days11.7017.7711.99
Days Payable0.000.000.00
Cash Conversion Cycle15.1120.5011.4529.5040.0921.0039.9337.2250.5831.2229.0136.98
Working Capital Days66.8656.76-35.32-26.83-17.34-32.27-53.37-25.47-3.10-32.29-16.60-37.12
ROCE %19.76%16.70%14.94%7.27%1.88%-2.62%-16.39%7.41%-1.49%2.77%5.82%3.97%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters19.65%19.65%19.65%19.65%19.65%19.65%19.65%19.65%19.65%19.65%19.65%19.65%
Public80.35%80.36%80.36%80.36%80.36%80.36%80.35%80.37%80.35%80.37%80.36%80.36%
No. of Shareholders1,3771,4121,4781,5401,5811,6561,6801,6771,6651,6801,6821,688

Fundamentals

Market Cap₹ 10.7 Cr.
Current Price₹ 26.0
Stock P/E20.9
Book Value₹ 25.6
ROCE3.97 %
ROE3.78 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)25%
Compounded Profit Growth (TTM)24%
Standalone figures.
Valuation
Market capRs 9 Cr
Enterprise valueRs 6 Cr
P/E (TTM)18.61x
Price to book0.90x
Price to sales0.34x
EV / EBITDA4.85x
EV / EBIT11.46x
EV / sales0.21x
Price to cash flow5.16x
Earnings yield5.37%
P/E, 3-year average34.95x
P/B, 3-year average0.98x
P/E, 5-year average29.80x
P/B, 5-year average0.86x
Profitability
Operating margin (excl. other income)2.98%
Operating margin (incl. other income)4.25%
EBITDA margin4.37%
Pre-tax margin1.81%
Net profit margin1.81%
Net margin, latest quarter2.31%
ROE3.78%
ROCE3.97%
ROA2.41%
ROE, 3-year average3.60%
ROCE, 3-year average4.19%
ROA, 3-year average2.34%
ROE, 5-year average2.75%
ROCE, 5-year average3.70%
ROA, 5-year average1.78%
ROIC (approx.)7.26%
Tax rate2.50%
Other income / net worth3.14%
Growth
Sales growth (latest year)14.17%
Profit growth (latest year)-23.53%
Sales CAGR, 3 years13.51%
Sales CAGR, 5 years21.47%
Sales growth QoQ7.73%
Profit growth QoQ-40.00%
Sales growth YoY (latest quarter)41.56%
Profit growth YoY (latest quarter)200.00%
Per share
EPS (TTM)Rs 1.21
EPS (latest year)Rs 0.93
EPS (latest quarter)Rs 0.43
EPS, 3-year averageRs 0.85
EPS, 5-year averageRs 0.64
Book value per shareRs 24.97
Sales per shareRs 66.88
Cash flow per shareRs 4.37
Free cash flow per shareRs 2.35
Efficiency
Asset turnover1.47x
Fixed asset turnover3.02x
Inventory turnover128.88x
Inventory days3 days
Debtor days37 days
Debtors turnover9.87x
Creditor days0 days
Cash conversion cycle37 days
Working capital days-37 days
Leverage
Cash and bankRs 4 Cr
Net debtRs -4 Cr
Net debt / EBITDA-2.87x
Interest coverage52.00x
Owners' fund to total sources59.82%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs 1 Cr
Cash from ops / profit, 5 years3.97x
Sales to cash flow14.05x
Statement figures
Net sales (TTM)Rs 28 Cr
Net sales (latest year)Rs 26 Cr
Sales (latest quarter)Rs 8 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 0 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 10 Cr
Total expenditure (latest year)Rs 25 Cr
Total income (latest year)Rs 26 Cr
Share capitalRs 4 Cr
ReservesRs 6 Cr
Shareholders' fundsRs 11 Cr
Total assetsRs 18 Cr
Net blockRs 9 Cr
ReceivablesRs 3 Cr
InventoryRs 0 Cr
Other liabilitiesRs 7 Cr
Shares outstanding (crore)0.42
Ownership
Promoter holding19.65% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 18.6 is at the 34th percentile of its own 6.4-year range (median 23.3, low 6.4, high 108.2).
P/B 0.90 is at the 63th percentile (median 0.73).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period531043Nifty 50Difference
1 week-9.6%-2.8% -6.8 pts
1 month-12.9%-6.8% -6.1 pts
3 months+12.2%-7.6% +19.8 pts
3 years+98.2%+14.2% +84.0 pts
5 years+134.9%+27.9% +107.0 pts

Red flags

F-score 5 of 8
explainReceivables outrunning sales Receivables grew 46% vs sales +14% in 2026
lookProfit leans on other income Other income was 82% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹8 Cr +41.6% vs Jun 2025. Net profit ₹0 Cr +200.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Dhanvantri Jeevan Rekha Ltd?

Dhanvantri Jeevan Rekha Ltd (531043) has a market capitalisation of Rs 10.7 Cr. at the 2026-10-01 close.

What is the P/E ratio of Dhanvantri Jeevan Rekha Ltd?

Dhanvantri Jeevan Rekha Ltd trades at a P/E of 20.9 on trailing twelve-month profit, at the 2026-10-01 close.

What were Dhanvantri Jeevan Rekha Ltd's latest quarterly results?

In the Jun 2026 quarter, Dhanvantri Jeevan Rekha Ltd sales was Rs 8 Cr (+41.6% vs Jun 2025) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03